JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A1971 Etoposide
4 Citation

Target: Topoisomerases

Summary: Topo II inhibitor

≥112.6 mg/mL
A5424 Fludarabine

Summary: DNA synthsis inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
A8803 RGFP966
4 Citation

Target: Histone Deacetylases (HDACs)

Summary: Specific HDAC3 inhibitor

insoluble in H2O; ≥18.12 mg/mL
B1963 Lomustine
1 Citation

Target: RNA synthesis

Summary: Antineoplastic drug

insoluble in H2O; ≥23.41 mg/mL
B4794 Santacruzamate A (CAY10683)

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor, potent and selective
B1470 Procarbazine HCl

Summary: Antineoplastic chemotherapy drug

≥12.82 mg/mL
A4099 Valproic acid sodium salt (Sodium valproate)

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥8.35 mg/mL